Monk BJ - Search Results

1

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Muggia FM, Blessing JA, McGehee R, Monk BJ. Muggia FM, et al. Among authors: monk bj. Gynecol Oncol. 2004 Aug;94(2):483-7. doi: 10.1016/j.ygyno.2004.05.018. Gynecol Oncol. 2004. PMID: 15297192 Clinical Trial.

2

Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery.

Monk BJ, Walker JL, Tewari K, Ramsinghani NS, Nisar Syed AM, DiSaia PJ. Monk BJ, et al. Gynecol Oncol. 1994 Feb;52(2):222-8. doi: 10.1006/gyno.1994.1035. Gynecol Oncol. 1994. PMID: 8314143

3

A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer.

Monk BJ, Tewari K, Burger RA, Johnson MT, Montz FJ, Berman ML. Monk BJ, et al. Gynecol Oncol. 1997 Dec;67(3):241-7. doi: 10.1006/gyno.1997.4877. Gynecol Oncol. 1997. PMID: 9441770

4

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.

Monk BJ, Alberts DS, Burger RA, Fanta PT, Hallum AV 3rd, Hatch KD, Salmon SE. Monk BJ, et al. Gynecol Oncol. 1998 Nov;71(2):308-12. doi: 10.1006/gyno.1998.5140. Gynecol Oncol. 1998. PMID: 9826477

5

Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.

Burger RA, DiSaia PJ, Roberts JA, O'rourke M, Gershenson DM, Homesley HD, Lichtman SM, Barnes W, Moore DH, Monk BJ. Burger RA, et al. Among authors: monk bj. Gynecol Oncol. 1999 Feb;72(2):148-53. doi: 10.1006/gyno.1998.5243. Gynecol Oncol. 1999. PMID: 10021293 Clinical Trial.

6

Development of an in vitro chemo-radiation response assay for cervical carcinoma.

Monk BJ, Burger RA, Parker R, Radany EH, Redpath L, Fruehauf JP. Monk BJ, et al. Gynecol Oncol. 2002 Nov;87(2):193-9. doi: 10.1006/gyno.2002.6818. Gynecol Oncol. 2002. PMID: 12477451

7

Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.

Yessaian A, Magistris A, Burger RA, Monk BJ. Yessaian A, et al. Among authors: monk bj. Gynecol Oncol. 2004 Jul;94(1):61-6. doi: 10.1016/j.ygyno.2004.04.016. Gynecol Oncol. 2004. PMID: 15262120

8

Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Morris M, Blessing JA, Monk BJ, McGehee R, Moore DH. Morris M, et al. Among authors: monk bj. J Clin Oncol. 2004 Aug 15;22(16):3340-4. doi: 10.1200/JCO.2004.12.006. J Clin Oncol. 2004. PMID: 15310778 Clinical Trial.

9

Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Bigler LR, Tate Thigpen J, Blessing JA, Fiorica J, Monk BJ; Gynecologic Oncology Group. Bigler LR, et al. Among authors: monk bj. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):871-4. doi: 10.1111/j.1048-891X.2004.14523.x. Int J Gynecol Cancer. 2004. PMID: 15361197 Clinical Trial.

10

Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma.

Chan JK, Sugiyama V, Tajalli TR, Pham H, Gu M, Rutgers J, Monk BJ. Chan JK, et al. Among authors: monk bj. Gynecol Oncol. 2004 Oct;95(1):152-6. doi: 10.1016/j.ygyno.2004.07.004. Gynecol Oncol. 2004. PMID: 15385125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters